Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 5 Breast Neoplasms 4 Stomach Neoplasms 3 Malnutrition 3 Head and Neck Neoplasms 3 Colonic Neoplasms 3 Wilms Tumor 1 Sarcoma 1 Prostatic Neoplasms 1 Prostatic Intraepithelial Neoplasia 1 Peripheral Nervous System Diseases 1 Peptic Ulcer 1 Pancreatic Neoplasms 1 Osteoporosis 1 Neurotoxicity Syndromes 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Myocardial Ischemia 1 Mucositis 1 Motor Activity 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma 1 Lung Neoplasms 1 Leukemia 1 Kidney Neoplasms 1 Inflammatory Bowel Diseases 1 Hyperphagia 1 Hepatitis C, Chronic 1 Hematologic Neoplasms 1 Heart Diseases 1

Interventions

Megestrol Acetate 6 Standard of Care 3 Exercise 3 Physical Therapy Modalities 2 Nutrition Assessment 2 Infliximab 2 Blood Specimen Collection 2 testosterone enanthate 1 remune 1 ostarine 1 olanzapine-fluoxetine combination 1 irinotecan sucrosofate 1 clazakizumab 1 bermekimab 1 anamorelin 1 Sodium Chloride 1 Radiotherapy 1 Preoperative Exercise 1 Powders 1 Pentoxifylline 1 Olanzapine 1 Nandrolone Decanoate 1 Mirtazapine 1 Melatonin 1 Megestrol 1 Immunologic Techniques 1 Ibuprofen 1 High-Energy Shock Waves 1 Ghrelin 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Cachexia × Dietary Supplements × Clear all

NCT02330926 2025-08-29

MENAC

Norwegian University of Science and Technology

Phase 3 Completed

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡